Xtl Biopharmaceuticals (XTLB) Cash from Operations (QoQ) (2009 - 2015)
Xtl Biopharmaceuticals (XTLB) Cash from Operations (QoQ) (2009 - 2015) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 970.55% |
| Sep 30, 2015 | 14.79% |
| Dec 31, 2014 | -48.13% |
| Sep 30, 2014 | 16.36% |
| Jun 30, 2014 | 31.74% |
| Mar 31, 2014 | -53.27% |
| Dec 31, 2013 | 31.40% |
| Sep 30, 2013 | -13.47% |
| Jun 30, 2013 | -20.80% |
| Mar 31, 2013 | -35.54% |
| Dec 31, 2012 | 13.38% |
| Sep 30, 2012 | -36.92% |
| Jun 30, 2012 | -21.55% |
| Mar 31, 2012 | -224.12% |
| Dec 31, 2011 | 192.68% |
| Sep 30, 2011 | 26.35% |
| Jun 30, 2011 | 18.34% |
| Mar 31, 2011 | -45.04% |
| Dec 31, 2010 | -34.93% |
| Sep 30, 2010 | -91.74% |